Improved perinatal depression screening, treatment, and outcomes with a universal obstetric program

Obstetrics and Gynecology

Volumn 127, Issue 5, 2016, Pages 917-925

  Avalos, Lyndsay A ^a   Raine Bennett, Tina ^a   Chen, Hong ^a   Adams, Alyce S ^a   Flanagan, Tracy ^a  

^a DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ATOMOXETINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DESVENLAFAXINE; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MILNACIPRAN; MIRTAZAPINE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRIMIPRAMINE; VENLAFAXINE; VILAZODONE;

ADULT; ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; DEMOGRAPHY; DEPRESSION; ELECTRONIC HEALTH RECORD; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MASS SCREENING; MATERNAL TREATMENT; PATIENT COUNSELING; PATIENT HEALTH QUESTIONNAIRE 9; PERINATAL DEPRESSION; PERINATAL PERIOD; PHARMACY; POPULATION RESEARCH; POSTNATAL CARE; POSTNATAL SCREENING; PRENATAL SCREENING; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TREND STUDY; YOUNG ADULT; ADOLESCENT; CALIFORNIA; DEPRESSION, POSTPARTUM; FACTUAL DATABASE; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; MATERNAL HEALTH SERVICE; OUTCOME ASSESSMENT; PERINATAL CARE; PRACTICE GUIDELINE; PREGNANCY; PSYCHOMETRY; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; CALIFORNIA; COHORT STUDIES; DATABASES, FACTUAL; DELIVERY OF HEALTH CARE; DEPRESSION, POSTPARTUM; FEMALE; HEALTH PLAN IMPLEMENTATION; HUMANS; MATERNAL HEALTH SERVICES; OUTCOME ASSESSMENT (HEALTH CARE); PERINATAL CARE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PSYCHOMETRICS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84964077826     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001403     Document Type: Article

References (32)

1. World Health Organization. The world health report 2001: mental health: new understanding. Geneva (Switzerland): New Hope; 2001.
2. Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T. Perinatal depression: A systematic review of prevalence and incidence. Obstet Gynecol 2005; 106:1071-83.
3. Li D, Liu L, Odouli R. Presence of depressive symptoms during early pregnancy and the risk of preterm delivery: A prospective cohort study. Hum Reprod 2009;24:146-53.
4. Beck CT. The effects of postpartum depression on maternalinfant interaction: A meta-Analysis. Nurs Res 1995;44:298-304.
5. Murray L. The impact of postnatal depression on infant development. J Child Psychol Psychiatry 1992;33:543-61.
6. Barr JA, Beck CT. Infanticide secrets: qualitative study on postpartum depression. Can Fam Physician 2008;54:1716-1717.e5.
7. Pearlstein T. Perinatal depression: Treatment options and dilemmas. J Psychiatry Neurosci 2008;33:302-18.
8. Smith MV, Rosenheck RA, Cavaleri MA, Howell HB, Poschman K, Yonkers KA. Screening for and detection of depression, panic disorder, and PTSD in public-sector obstetric clinics. Psychiatr Serv 2004;55:407-14.
9. LaRocco-Cockburn A, Melville J, Bell M, Katon W. Depression screening attitudes and practices among obstetrician-gynecologists. Obstet Gynecol 2003;101:892-8.
10. Olson AL, Kemper KJ, Kelleher KJ, Hammond CS, Zuckerman BS, Dietrich AJ. Primary care pediatricians' roles and perceived responsibilities in the identification and management of maternal depression. Pediatrics 2002;110:1169-76.
11. National Institute for Healthcare Management Foundation. Identifying and treating maternal depression: strategies & considerations for health plans. Washington, DC: National Institute for Healthcare Management Foundation; 2010.
12. Committee on Obstetric Practice. Screening for perinatal depression. Committee Opinion No. 630. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015; 125:1268-71.
13. Flanagan T, Avalos LA. Perinatal obstetric office depression screening and treatment: implementation in a health care system. Obstet Gynecol 2016;127:911-5.
14. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-13.
15. Spitzer RL, Williams JB, Kroenke K, Hornyak R, McMurray J. Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: The PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study. Am J Obstet Gynecol 2000;183:759-69.
16. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999;282:1737-44.
17. Gilbody S, Richards D, Brealey S, Hewitt C. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): A diagnostic meta-Analysis. J Gen Intern Med 2007;22:1596-602.
18. Wittkampf KA, Naeije L, Schene AH, Huyser J, van Weert HC. Diagnostic accuracy of the mood module of the Patient Health Questionnaire: A systematic review. Gen Hosp Psychiatry 2007; 29:388-95.
19. Löwe B, Unutzer J, Callahan CM, Perkins AJ, Kroenke K. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care 2004;42:1194-201.
20. Yawn BP, Dietrich AJ, Wollan P, Bertram S, Graham D, Huff J, et al. TRIPPD: A practice-based network effectiveness study of postpartum depression screening and management. Ann Fam Med 2012;10:320-9.
21. Myers ER, Aubuchon-Endsley N, Bastian LA, Gierisch JM, Kemper AR, Swamy GK, et al. In: Efficacy and safety of screening for postpartum depression. Rockville (MD): Agency for Healthcare Research and Quality; 2013.
22. Dietz PM, Williams SB, Callaghan WM, Bachman DJ, Whitlock EP, Hornbrook MC. Clinically identified maternal depression before, during, and after pregnancies ending in live births. Am J Psychiatry 2007;164:1515-20.
23. Ko JY, Farr SL, Dietz PM, Robbins CL. Depression and treatment among U.S. pregnant and nonpregnant women of reproductive age, 2005-2009. J Womens Health (Larchmt) 2012;21: 830-6.
24. Vesga-López O, Blanco C, Keyes K, Olfson M, Grant BF, Hasin DS. Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry 2008;65: 805-15.
25. Kelly R, Zatzick D, Anders T. The detection and treatment of psychiatric disorders and substance use among pregnant women cared for in obstetrics. Am J Psychiatry 2001;158: 213-9.
26. Marcus SM, Flynn HA, Blow FC, Barry KL. Depressive symptoms among pregnant women screened in obstetrics settings. J Womens Health (Larchmt) 2003;12:373-80.
27. Flynn HA, Blow FC, Marcus SM. Rates and predictors of depression treatment among pregnant women in hospitalaffiliated obstetrics practices. Gen Hosp Psychiatry 2006;28: 289-95.
28. Dennis CL, Chung-Lee L. Postpartum depression help-seeking barriers and maternal treatment preferences: A qualitative systematic review. Birth 2006;33:323-31.
29. Goodman JH. Women's attitudes, preferences, and perceived barriers to treatment for perinatal depression. Birth 2009;36: 60-9.
30. Cooper JE. Detection and management of psychiatric disorders in primary care. Br J Psychiatry 2003;182:1-2.
31. Holden JM, Sagovsky R, Cox JL. Counselling in a general practice setting: controlled study of health visitor intervention in treatment of postnatal depression. BMJ 1989;298: 223-6.
32. O'Connor E, Rossom RC, Henninger M, Groom HC, Burda BU. Primary care screening for and treatment of depression in pregnant and postpartum women: evidence report and systematic review for the US Preventive Services Task Force. JAMA 2016;315:388-406.